192 related articles for article (PubMed ID: 31455338)
1. Predictive value of a series of inflammatory markers in COPD for lung cancer diagnosis: a case-control study.
Mouronte-Roibás C; Leiro-Fernández V; Ruano-Raviña A; Ramos-Hernández C; Casado-Rey P; Botana-Rial M; García-Rodríguez E; Fernández-Villar A
Respir Res; 2019 Aug; 20(1):198. PubMed ID: 31455338
[TBL] [Abstract][Full Text] [Related]
2. The neutrophil/lymphocyte ratio is a better addition to C-reactive protein than CD64 index as a marker for infection in COPD.
Farah R; Ibrahim R; Nassar M; Najib D; Zivony Y; Eshel E
Panminerva Med; 2017 Sep; 59(3):203-209. PubMed ID: 28185443
[TBL] [Abstract][Full Text] [Related]
3. Elevated circulating PAI-1 levels are related to lung function decline, systemic inflammation, and small airway obstruction in chronic obstructive pulmonary disease.
Wang H; Yang T; Li D; Wu Y; Zhang X; Pang C; Zhang J; Ying B; Wang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2016; 11():2369-2376. PubMed ID: 27713627
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein levels in stable COPD patients: a case-control study.
Silva DR; Gazzana MB; Knorst MM
Int J Chron Obstruct Pulmon Dis; 2015; 10():1719-25. PubMed ID: 26357470
[TBL] [Abstract][Full Text] [Related]
5. Predictive Value of Combining Inflammatory Biomarkers and Rapid Decline of FEV
Wang Y; Liao J; Zhong Y; Zhang C; Li X; Wang G
Int J Chron Obstruct Pulmon Dis; 2019; 14():2825-2833. PubMed ID: 31824147
[TBL] [Abstract][Full Text] [Related]
6. The utility of inflammatory markers to predict readmissions and mortality in COPD cases with or without eosinophilia.
Duman D; Aksoy E; Agca MC; Kocak ND; Ozmen I; Akturk UA; Gungor S; Tepetam FM; Eroglu SA; Oztas S; Karakurt Z
Int J Chron Obstruct Pulmon Dis; 2015; 10():2469-78. PubMed ID: 26648709
[TBL] [Abstract][Full Text] [Related]
7. Airway inflammation in Japanese COPD patients compared with smoking and nonsmoking controls.
Ishikawa N; Hattori N; Kohno N; Kobayashi A; Hayamizu T; Johnson M
Int J Chron Obstruct Pulmon Dis; 2015; 10():185-92. PubMed ID: 25670894
[TBL] [Abstract][Full Text] [Related]
8. Oxidative stress and inflammation in the normal airways and blood of patients with lung cancer and COPD.
Barreiro E; Fermoselle C; Mateu-Jimenez M; Sánchez-Font A; Pijuan L; Gea J; Curull V
Free Radic Biol Med; 2013 Dec; 65():859-871. PubMed ID: 23954470
[TBL] [Abstract][Full Text] [Related]
9. Lung cancer in patients with chronic obstructive pulmonary disease. Development and validation of the COPD Lung Cancer Screening Score.
de-Torres JP; Wilson DO; Sanchez-Salcedo P; Weissfeld JL; Berto J; Campo A; Alcaide AB; García-Granero M; Celli BR; Zulueta JJ
Am J Respir Crit Care Med; 2015 Feb; 191(3):285-91. PubMed ID: 25522175
[TBL] [Abstract][Full Text] [Related]
10. Serum IL-1β and IL-17 levels in patients with COPD: associations with clinical parameters.
Zou Y; Chen X; Liu J; Zhou DB; Kuang X; Xiao J; Yu Q; Lu X; Li W; Xie B; Chen Q
Int J Chron Obstruct Pulmon Dis; 2017; 12():1247-1254. PubMed ID: 28490868
[TBL] [Abstract][Full Text] [Related]
11. A gender difference in circulating neutrophils in malnourished patients with COPD.
Larsson S; Nordenson A; Glader P; Yoshihara S; Lindén A; Slinde F
Int J Chron Obstruct Pulmon Dis; 2011; 6():83-8. PubMed ID: 21407820
[TBL] [Abstract][Full Text] [Related]
12. 2017 Global Initiative for Chronic Obstructive Lung Disease reclassifies half of COPD subjects to lower risk group.
Högman M; Sulku J; Ställberg B; Janson C; Bröms K; Hedenström H; Lisspers K; Malinovschi A
Int J Chron Obstruct Pulmon Dis; 2018; 13():165-173. PubMed ID: 29379281
[TBL] [Abstract][Full Text] [Related]
13. Comparative analysis of COPD associated with tobacco smoking, biomass smoke exposure or both.
Olloquequi J; Jaime S; Parra V; Cornejo-Córdova E; Valdivia G; Agustí À; Silva O R
Respir Res; 2018 Jan; 19(1):13. PubMed ID: 29347936
[TBL] [Abstract][Full Text] [Related]
14. Differences in systemic inflammation between cigarette and biomass smoke-induced COPD.
Golpe R; Martín-Robles I; Sanjuán-López P; Pérez-de-Llano L; González-Juanatey C; López-Campos JL; Arellano-Orden E
Int J Chron Obstruct Pulmon Dis; 2017; 12():2639-2646. PubMed ID: 28979110
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-lymphocyte ratio in chronic obstructive pulmonary disease: a retrospective study.
Günay E; Sarınç Ulaşlı S; Akar O; Ahsen A; Günay S; Koyuncu T; Unlü M
Inflammation; 2014 Apr; 37(2):374-80. PubMed ID: 24078279
[TBL] [Abstract][Full Text] [Related]
16. The Role of Mean Platelet Volume in Chronic Obstructive Pulmonary Disease Exacerbation.
Agapakis DI; Massa EV; Hantzis I; Maraslis S; Alexiou E; Imprialos KP; Damianidou M; Satsoglou E
Respir Care; 2016 Jan; 61(1):44-9. PubMed ID: 26604328
[TBL] [Abstract][Full Text] [Related]
17. Risk factors for lung cancer in COPD - results from the Bergen COPD cohort study.
Husebø GR; Nielsen R; Hardie J; Bakke PS; Lerner L; D'Alessandro-Gabazza C; Gyuris J; Gabazza E; Aukrust P; Eagan T
Respir Med; 2019 Jun; 152():81-88. PubMed ID: 31128615
[TBL] [Abstract][Full Text] [Related]
18. Serum cytokine profiling and enrichment analysis reveal the involvement of immunological and inflammatory pathways in stable patients with chronic obstructive pulmonary disease.
Bade G; Khan MA; Srivastava AK; Khare P; Solaiappan KK; Guleria R; Palaniyar N; Talwar A
Int J Chron Obstruct Pulmon Dis; 2014; 9():759-73. PubMed ID: 25125975
[TBL] [Abstract][Full Text] [Related]
19. Increased serum TRAIL and DR5 levels correlated with lung function and inflammation in stable COPD patients.
Wu Y; Shen Y; Zhang J; Wan C; Wang T; Xu D; Yang T; Wen F
Int J Chron Obstruct Pulmon Dis; 2015; 10():2405-12. PubMed ID: 26609227
[TBL] [Abstract][Full Text] [Related]
20. Inter-alpha-trypsin inhibitor heavy chain 4: a novel biomarker for environmental exposure to particulate air pollution in patients with chronic obstructive pulmonary disease.
Lee KY; Feng PH; Ho SC; Chuang KJ; Chen TT; Su CL; Liu WT; Chuang HC
Int J Chron Obstruct Pulmon Dis; 2015; 10():831-41. PubMed ID: 25977605
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]